Published January 22, 2025 | Version v1
Journal article Open

Major Constituent and Mode of Action of Snake Venom and the Nullifying Activity of both Synthetic and Herbal Remedies

Authors/Creators

Contributors

Hosting institution:

Description

The issues of snakebite have been foremost socio-medical challenge disturbing numerous societies worldwide, most exclusively Asian and African continents as whole. The cure is still reliant on the use of antisera as the key means of management, which has been greatly limited. Hospitals in rural societies are substandard; treatment of snakebite is often handled by traditional doctors either due to the cost or unavailability of synthetic antivenins. Venom of diverse snake class has a unique constituent; this constituent could be altered by other dynamics for instance geographical, age, seasonal disparities and sex. Usually, snake venom constituting minute molecules for example protein, enzymatic absorption, inorganic cations and peptides. However, snake bite envenomation is extremely related to mortality after systemic circulation of the venom, certain examinations reveal that snake venom’s constituent possesses inherent medicinal significance. The modus operandi of synthetic antivenin as well as the anti-venom obtained from certain plant materials and the major constituent found in snake venom (phospholipases a2, disintegrins, snake venom serine proteinases, alpha-neurotoxins, activity of fibrinolytic enzyme and three-finger toxins) are discussed in detail in this review. Some selected theories that proposed the mechanism of action of compounds obtained from herbal sources to combat snakebite such as enhancing/modifying action, protein precipitation, chelating properties and enzyme deactivation have been discussed.

Files

Files (204.2 kB)

Name Size Download all
md5:72c53af2f5947370a449c246e84fa6ec
204.2 kB Download

Additional details

Identifiers

URL
https://journal.medtigo.com/major-constituent-and-mode-of-action-of-snake-venom-and-the-nullifying-activity-of-both-synthetic-and-herbal-remedies/

Related works

Is published in
Journal: 3065-4661 (ISSN)

Dates

Accepted
2025-01-17

References

  • 1. Matsui T, Fujimura Y, Titani K. Snake venom proteases affecting hemostasis and thrombosis. Biochim Biophys Acta. 2000;1477(1-2):146-156. doi:10.1016/s0167-4838(99)00268-x
  • 2. Chan YS, Cheung RCF, Xia L, Wong JH, Ng TB, Chan WY. Snake venom toxins: toxicity and medicinal applications. Appl Microbiol Biotechnol. 2016;100(14):6165-6181. doi:10.1007/s00253-016-7610-9
  • 3. Vyas VK, Brahmbhatt K, Bhatt H, Parmar U. Therapeutic potential of snake venom in cancer therapy: current perspectives. Asian Pac J Trop Biomed. 2013;3(2):156-162. doi:10.1016/S2221-1691(13)60042-8
  • 4. Sanhajariya S, Duffull SB, Isbister GK. Pharmacokinetics of Snake Venom. Toxins (Basel). 2018;10(2):73. doi:10.3390/toxins10020073
  • 5. Chippaux JP, Williams V, White J. Snake venom variability: methods of study, results and interpretation. Toxicon. 1991;29(11):1279-1303. doi:10.1016/0041-0101(91)90116-9
  • 6. Tasoulis T, Isbister GK. A Review and Database of Snake Venom Proteomes. Toxins (Basel). 2017;9(9):290. doi:10.3390/toxins9090290
  • 7. Slagboom J, Kool J, Harrison RA, Casewell NR. Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise. Br J Haematol. 2017;177(6):947-959. doi:10.1111/bjh.14591
  • 8. Harris JB, Scott-Davey T. Secreted phospholipases A2 of snake venoms: effects on the peripheral neuromuscular system with comments on the role of phospholipases A2 in disorders of the CNS and their uses in industry. Toxins (Basel). 2013;5(12):2533-2571. doi:10.3390/toxins5122533
  • 9. Vonk FJ, Casewell NR, Henkel CV, et al. The king cobra genome reveals dynamic gene evolution and adaptation in the snake venom system. Proc Natl Acad Sci U S A. 2013;110(51):20651-20656. doi:10.1073/pnas.1314702110
  • 10. Lynch VJ. Inventing an arsenal: adaptive evolution and neofunctionalization of snake venom phospholipase A2 genes. BMC Evol Biol. 2007;7:2. doi:10.1186/1471-2148-7-2
  • 11. Fry BG, Scheib H, Junqueira de Azevedo ILM, Silva DA, Casewell NR. Novel transcripts in the maxillary venom glands of advanced snakes. Toxicon. 2012;59(6):696-708. doi:10.1016/j.toxicon.2012.03.005
  • 12. Haruna AK, Choudhury MK. In vivo antisnake venom activity of a furanoid diterpene from Aristolochia albida Duch (Aristolochiaceae). Indian J Pharm Sci. 1995;57(5):222. https://www.ijpsonline.com/articles/in-vivo-antisnake-venom-activity-of-a-furanoid-diterpene-from-aristolochia-albida-duch-aristolochiaceae.pdf
  • 13. Theakston RD, Reid HA. Development of simple standard assay procedures for the characterization of snake venom. Bull World Health Organ. 1983;61(6):949-956. https://pubmed.ncbi.nlm.nih.gov/6609011/
  • 14. Soares A, Januario AH, Lourenço MV, Pereira PS. Neutralizing effects of Brazilian plants against snake venoms. Drugs Future. 2004;29(11). doi:10.1358/dof.2004.029.11.851973
  • 15. Tohamy AA, Mohamed AF, Abdel Moneim AE, Diab MSM. Biological effects of Naja haje crude venom on the hepatic and renal tissues of mice. J King Saud Univ Sci. 2014;26(3):205-212. doi:10.1016/j.jksus.2014.01.003
  • 16. Goje L, Aisami A, Maigari F, et al. The anti-snake venom effects of the aqueous extracts of Boswellia delzielli stem bark on the parameters of hepatic functions and energy metabolism of Naja nigricollis (spitting cobra) envenomed albino rats. J Interdisciplinary Research. 2013;1. https://www.researchgate.net/publication/318721446_The_Anti_Snake_Venom_Effects_of_the_Aqueous_Extracts_of_Boswellia_delzielli_Stem_Bark_on_the_Parameters_of_Hepatic_Functions_and_Energy_Metabolism_of_Naja_nigricollis_Spitting_Cobra_Envenomed_Albino_R
  • 17. Hossain J, Biswas A, Rahman F, Mashreky SR, Dalal K, Rahman A. Snakebite epidemiology in Bangladesh—a national community-based health and injury survey. Health. 2016;8(5). doi: 10.4236/health.2016.85051
  • 18. Lu Q, Clemetson JM, Clemetson KJ. Snake venoms and hemostasis. J Thromb Haemost. 2005;3(8):1791-1799. doi:10.1111/j.1538-7836.2005.01358.x
  • 19. Kini RM. Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochem J. 2006;397(3):377-387. doi:10.1042/BJ20060302
  • 20. Patel R. Ferrous ion chelating activity (FICA)—a comparative antioxidant activity evaluation of extracts of eleven naturally growing plants of Gujarat, India. Int J Sci Res. 2012;2:426-428. doi:10.15373/22778179/AUG2013/142.
  • 21. Six DA, Dennis EA. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta. 2000;1488(1-2):1-19. doi:10.1016/s1388-1981(00)00105-0
  • 22. Perry BW, Card DC, McGlothlin JW, et al. Molecular Adaptations for Sensing and Securing Prey and Insight into Amniote Genome Diversity from the Garter Snake Genome. Genome Biol Evol. 2018;10(8):2110-2129. doi:10.1093/gbe/evy157
  • 23. Junqueira-de-Azevedo IL, Bastos CM, Ho PL, Luna MS, Yamanouye N, Casewell NR. Venom-related transcripts from Bothrops jararaca tissues provide novel molecular insights into the production and evolution of snake venom. Mol Biol Evol. 2015;32(3):754-766. doi:10.1093/molbev/msu337
  • 24. Lomonte B, Rangel J. Snake venom Lys49 myotoxins: From phospholipases A(2) to non-enzymatic membrane disruptors. Toxicon. 2012;60(4):520-530. doi:10.1016/j.toxicon.2012.02.007
  • 25. Dowell NL, Giorgianni MW, Kassner VA, Selegue JE, Sanchez EE, Carroll SB. The Deep Origin and Recent Loss of Venom Toxin Genes in Rattlesnakes. Curr Biol. 2016;26(18):2434-2445. doi:10.1016/j.cub.2016.07.038
  • 26. Vonk F, Casewell N, Henkel C, et al. The king cobra genome reveals dynamic gene evolution and adaptation in the snake venom system. Proc Natl Acad Sci U S A. 2013;110(51):20651-20656. doi:10.1073/pnas.1314702110
  • 27. Leiguez E, Giannotti KC, Viana MDN, et al. A Snake Venom-Secreted Phospholipase A2 Induces Foam Cell Formation Depending on the Activation of Factors Involved in Lipid Homeostasis. Mediators Inflamm. 2018;2018:2547918. doi:10.1155/2018/2547918
  • 28. Mora-Obando D, Díaz C, Angulo Y, Gutiérrez JM, Lomonte B. Role of enzymatic activity in muscle damage and cytotoxicity induced by Bothrops asper Asp49 phospholipase A2 myotoxins: are there additional effector mechanisms involved?. PeerJ. 2014;2:e569. doi:10.7717/peerj.569
  • 29. Wickramaratna JC, Fry BG, Aguilar MI, Kini RM, Hodgson WC. Isolation and pharmacological characterization of a phospholipase A2 myotoxin from the venom of the Irian Jayan death adder (Acanthophis rugosus). Br J Pharmacol. 2003;138(2):333-342. doi:10.1038/sj.bjp.0705046
  • 30. Cicala C, Cirino G. Phospholipase A2-induced hypotension in the rat and its pharmacological modulation. Gen Pharmacol Vasc Syst. 1993;24(5):1197-1202. doi:10.1016/0306-3623(93)90368-8
  • 31. Kakumanu R, Kemp-Harper BK, Silva A, Kuruppu S, Isbister GK, Hodgson WC. An in vivo examination of the differences between rapid cardiovascular collapse and prolonged hypotension induced by snake venom. Sci Rep. 2019;9(1):20231. doi:10.1038/s41598-019-56643-0
  • 32. Chaisakul J, Isbister GK, Tare M, Parkington HC, Hodgson WC. Hypotensive and vascular relaxant effects of phospholipase A2 toxins from Papuan taipan (Oxyuranus scutellatus) venom. Eur J Pharmacol. 2014;723:227-233. doi:10.1016/j.ejphar.2013.11.028
  • 33. Silveira LB, Marchi-Salvador DP, Santos-Filho NA, et al. Isolation and expression of a hypotensive and anti-platelet acidic phospholipase A2 from Bothrops moojeni snake venom. J Pharm Biomed Anal. 2013;73:35-43. doi:10.1016/j.jpba.2012.04.008
  • 34. de Andrade CM, Rey FM, Cintra ACO, Sampaio SV, Torqueti MR. Effects of crotoxin, a neurotoxin from Crotalus durissus terrificus snake venom, on human endothelial cells. Int J Biol Macromol. 2019;134:613-621. doi:10.1016/j.ijbiomac.2019.05.019
  • 35. Rivas-Mercado EA, Garza-Ocañas L. Disintegrins obtained from snake venom and their pharmacological potential. Med Univ. 2017;19(74):32-37. https://www.researchgate.net/publication/318449974_Disintegrins_obtained_from_snake_venom_and_their_pharmacological_potential/fulltext/5e7901e7a6fdcceef972fd21/Disintegrins-obtained-from-snake-venom-and-their-pharmacological-potential.pdf
  • 36. Arruda Macêdo JK, Fox JW, de Souza Castro M. Disintegrins from snake venoms and their applications in cancer research and therapy. Curr Protein Pept Sci. 2015;16(6):532-548. doi:10.2174/1389203716666150515125002
  • 37. Cañas CA, Castaño-Valencia S, Castro-Herrera F, Cañas F, Tobón GJ. Biomedical applications of snake venom: from basic science to autoimmunity and rheumatology. J Transl Autoimmun. 2020;4:100076. doi:10.1016/j.jtauto.2020.100076
  • 38. Cook JJ, Huang TF, Rucinski B, et al. Inhibition of platelet hemostatic plug formation by trigramin, a novel RGD-peptide. Am J Physiol. 1989;256(4 Pt 2):H1038-H1043. doi:10.1152/ajpheart.1989.256.4.H1038
  • 39. Huang TF, Ouyang C. Action mechanism of the potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Thromb Res. 1984;33(2):125-138. doi:10.1016/0049-3848(84)90173-7
  • 40. Vaiyapuri S, Thiyagarajan N, Hutchinson EG, Gibbins JM. Sequence and phylogenetic analysis of viper venom serine proteases. Bioinformation. 2012;8(16):763-772. doi:10.6026/97320630008763
  • 41. Serrano SM. The long road of research on snake venom serine proteinases. Toxicon. 2013;62:19-26. doi:10.1016/j.toxicon.2012.09.003
  • 42. Page MJ, Di Cera E. Serine peptidases: classification, structure and function. Cell Mol Life Sci. 2008;65(7-8):1220-1236. doi:10.1007/s00018-008-7565-9
  • 43. Modahl CM, Frietze S, Mackessy SP. Transcriptome-facilitated proteomic characterization of rear-fanged snake venoms reveal abundant metalloproteinases with enhanced activity. J Proteomics. 2018;187:223-234. doi:10.1016/j.jprot.2018.08.004
  • 44. Kang TS, Georgieva D, Genov N, et al. Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis. FEBS J. 2011;278(23):4544-4576. doi:10.1111/j.1742-4658.2011.08115.x
  • 45. Murakami MT, Arni RK. Thrombomodulin-independent activation of protein C and specificity of hemostatically active snake venom serine proteinases: crystal structures of native and inhibited Agkistrodon contortrix contortrix protein C activator. J Biol Chem. 2005;280(47):39309-39315. doi:10.1074/jbc.M508502200
  • 46. Yip J, Shen Y, Berndt MC, Andrews RK. Primary platelet adhesion receptors. IUBMB Life. 2005;57(2):103-108. doi:10.1080/15216540500078962
  • 47. Menaldo DL, Bernardes CP, Pereira JC, et al. Effects of two serine proteases from Bothrops pirajai snake venom on the complement system and the inflammatory response. Int Immunopharmacol. 2013;15(4):764-771. doi:10.1016/j.intimp.2013.02.023
  • 48. Zychar B, Dale C, Demarchi D, Gonçalves L. Contribution of metalloproteases, serine proteases and phospholipases A(2) to the inflammatory reaction induced by Bothrops jararaca crude venom in mice. Toxicon. 2009;55(2):227-234. doi:10.1016/j.toxicon.2009.07.025
  • 49. He YY, Lee WH, Zhang Y. Cloning and purification of alpha-neurotoxins from king cobra (Ophiophagus hannah). Toxicon. 2004;44(3):295-303. doi:10.1016/j.toxicon.2004.06.003
  • 50. DIDISHEIM P, LEWIS JH. Fibrinolytic and coagulant activities of certain snake venoms and proteases. Proc Soc Exp Biol Med. 1956;93(1):10-13. doi:10.3181/00379727-93-22647
  • 51. Trikha M, Schmitmeier S, Markland FS. Purification and characterization of fibrolase isoforms from venom of individual southern copperhead (Agkistrodon contortrix Contortrix) snakes. Toxicon. 1994;32(12):1521-1531. doi:10.1016/0041-0101(94)90310-7
  • 52. Ahmed NK, Gaddis RR, Tennant KD, Lacz JP. Biological and thrombolytic properties of fibrolase--a new fibrinolytic protease from snake venom. Haemostasis. 1990;20(6):334-340. doi:10.1159/000216147
  • 53. Swenson S, Bush LR, Markland FS. Chimeric derivative of fibrolase, a fibrinolytic enzyme from southern copperhead venom, possesses inhibitory activity on platelet aggregation. Arch Biochem Biophys. 2000;384(2):227-237. doi:10.1006/abbi.2000.2129
  • 54. Siigur J, Samel M, Tõnismägi K, Subbi J, Siigur E, Tu AT. Biochemical characterization of lebetase, a direct-acting fibrinolytic enzyme from Vipera lebetina snake venom. Thromb Res. 1998;90(1):39-49. doi:10.1016/s0049-3848(98)00009-7
  • 55. Alfimeprase. Drugs R D. 2008;9(3):185-190. doi:10.2165/00126839-200809030-00006
  • 56. Girish VM, Kumar S, Joseph L, Jobichen C, Kini RM, Sivaraman J. Identification and structural characterization of a new three-finger toxin hemachatoxin from Hemachatus haemachatus venom. PLoS One. 2012;7(10):e48112. doi:10.1371/journal.pone.0048112
  • 57. Ferraz CR, Arrahman A, Xie C, et al. Multifunctional toxins in snake venoms and therapeutic implications: from pain to hemorrhage and necrosis. Front Ecol Evol. 2019;7:Article 218. doi:10.3389/fevo.2019.00218
  • 58. Watanabe TX, Itahara Y, Kuroda H, Chen YN, Kimura T, Sakakibara S. Smooth muscle relaxing and hypotensive activities of synthetic calciseptine and the homologous snake venom peptide FS2. Jpn J Pharmacol. 1995;68(3):305-313. doi:10.1254/jjp.68.305
  • 59. de Weille JR, Schweitz H, Maes P, Tartar A, Lazdunski M. Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel. Proc Natl Acad Sci U S A. 1991;88(6):2437-2440. doi:10.1073/pnas.88.6.2437
  • 60. Koivula K, Rondinelli S, Näsman J. The three-finger toxin MTalpha is a selective alpha(2B)-adrenoceptor antagonist. Toxicon. 2010;56(3):440-447. doi:10.1016/j.toxicon.2010.05.001
  • 61. Chanda C, Sarkar A, Sistla S, Chakrabarty D. Anti-platelet activity of a three-finger toxin (3FTx) from Indian monocled cobra (Naja kaouthia) venom. Biochem Biophys Res Commun. 2013;441(3):550-554. doi:10.1016/j.bbrc.2013.10.125
  • 62. Ainsworth S, Slagboom J, Alomran N, et al. The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms. Commun Biol. 2018;34(1). doi:10.1038/s42003-018-0039-1
  • 63. Roncolato EC, Campos LB, Pessenda G, Costa e Silva L, Furtado GP, Barbosa JE. Phage display as a novel promising antivenom therapy: a review. Toxicon. 2015;93:79-84. doi:10.1016/j.toxicon.2014.11.001
  • 64. Maduwage K, Isbister GK. Current treatment for venom-induced consumption coagulopathy resulting from snakebite. PLoS Negl Trop Dis. 2014;8(10):e3220. doi:10.1371/journal.pntd.0003220
  • 65. Abubakar IS, Abubakar SB, Habib AG, et al. Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria. PLoS Negl Trop Dis. 2010;4(7):e767. doi:10.1371/journal.pntd.0000767
  • 66. O'Leary MA, Isbister GK. Commercial monovalent antivenoms in Australia are polyvalent. Toxicon. 2009;54(2):192-195. doi:10.1016/j.toxicon.2009.04.004
  • 67. Deshpande RP, Motghare VM, Padwal SL, et al. Adverse drug reaction profile of anti-snake venom in a rural tertiary care teaching hospital. J Young Pharm. 2013;5(2):41-45. doi:10.1016/j.jyp.2013.02.003
  • 68. Hoogenboom HR. Selecting and screening recombinant antibody libraries. Nat Biotechnol. 2005;23(9):1105-1116. doi:10.1038/nbt1126
  • 69. Durban J, Sanz L, Trevisan-Silva D, Neri-Castro E, Alagón A, Calvete JJ. Integrated Venomics and Venom Gland Transcriptome Analysis of Juvenile and Adult Mexican Rattlesnakes Crotalus simus, C. tzabcan, and C. culminatus Revealed miRNA-modulated Ontogenetic Shifts. J Proteome Res. 2017;16(9):3370-3390. doi:10.1021/acs.jproteome.7b00414
  • 70. Gibbs HL, Sanz L, Sovic MG, Calvete JJ. Phylogeny-based comparative analysis of venom proteome variation in a clade of rattlesnakes (Sistrurus sp.). PLoS One. 2013;8(6):e67220. doi:10.1371/journal.pone.0067220
  • 71. Tan CH, Tan NH, Tan KY, Kwong KO. Antivenom cross-neutralization of the venoms of Hydrophis schistosus and Hydrophis curtus, two common sea snakes in Malaysian waters. Toxins (Basel). 2015;7(2):572-581. doi:10.3390/toxins7020572
  • 72. Pla D, Sanz L, Molina-Sánchez P, et al. Snake venomics of Lachesis muta rhombeata and genus-wide antivenomics assessment of the paraspecific immunoreactivity of two antivenoms evidence the high compositional and immunological conservation across Lachesis. J Proteomics. 2013;89:112-123. doi:10.1016/j.jprot.2013.05.028
  • 73. Calvete JJ, Sanz L, Angulo Y, Lomonte B, Gutiérrez JM. Venoms, venomics, antivenomics. FEBS Lett. 2009;583(11):1736-1743. doi:10.1016/j.febslet.2009.03.029
  • 74. Madrigal M, Sanz L, Flores-Díaz M, et al. Snake venomics across genus Lachesis. Ontogenetic changes in the venom composition of Lachesis stenophrys and comparative proteomics of the venoms of adult Lachesis melanocephala and Lachesis acrochorda. J Proteomics. 2012;77:280-297. doi:10.1016/j.jprot.2012.09.003
  • 75. Whiteley G, Casewell NR, Pla D, et al. Defining the pathogenic threat of envenoming by South African shield-nosed and coral snakes (genus Aspidelaps), and revealing the likely efficacy of available antivenom. J Proteomics. 2019;198:186-198. doi:10.1016/j.jprot.2018.09.019
  • 76. Alam MI, Gomes A. Adjuvant effects and antiserum action potentiation by a (herbal) compound 2-hydroxy-4-methoxy benzoic acid isolated from the root extract of the Indian medicinal plant 'sarsaparilla' (Hemidesmus indicus R. Br.). Toxicon. 1998;36(10):1423-1431. doi:10.1016/s0041-0101(98)00076-2
  • 77. Vale LH, Mendes MM, Hamaguchi A, Soares AM, Rodrigues VM, Homsi-Brandeburgo MI. Neutralization of pharmacological and toxic activities of bothrops snake venoms by Schizolobium parahyba (Fabaceae) aqueous extract and its fractions. Basic Clin Pharmacol Toxicol. 2008;103(1):104-107. doi:10.1111/j.1742-7843.2008.00248.x
  • 78. Hung YC, Sava V, Hong MY, Huang GS. Inhibitory effects on phospholipase A2 and antivenin activity of melanin extracted from Thea sinensis Linn. Life Sci. 2004;74(16):2037-2047. doi:10.1016/j.lfs.2003.09.048
  • 79. Castro O, Gutiérrez JM, Barrios M, Castro I, Romero M, Umaña E. Neutralización del efecto hemorrágico inducido por veneno de Bothrops asper (Serpentes: Viperidae) por extractos de plantas tropicales [Neutralization of the hemorrhagic effect induced by Bothrops asper (Serpentes: Viperidae) venom with tropical plant extracts]. Rev Biol Trop. 1999;47(3):605-616. doi:10.15517/rbt.v47i3.19215
  • 80. Chatterjee I, Chakravarty AK, Gomes A. Daboia russellii and Naja kaouthia venom neutralization by lupeol acetate isolated from the root extract of Indian sarsaparilla Hemidesmus indicus R.Br. J Ethnopharmacol. 2006;106(1):38-43. doi:10.1016/j.jep.2005.11.031
  • 81. Gomes A, Das R, Sarkhel S, et al. Herbs and herbal constituents active against snake bite. Indian J Exp Biol. 2010;48(9):865-878. https://pubmed.ncbi.nlm.nih.gov/21506494/
  • 82. Gupta YK. Snake bite in India: Current scenario of an old problem. J Clin Toxicol. 2014;4(1). doi:10.4172/2161-0495.1000182
  • 83. Nishijima CM, Rodrigues CM, Silva MA, Lopes-Ferreira M, Vilegas W, Hiruma-Lima CA. Anti-hemorrhagic activity of four Brazilian vegetable species against Bothrops jararaca venom. Molecules. 2009;14(3):1072-1080. doi:10.3390/molecules14031072
  • 84. Sunitha K, Hemshekhar M, Santhosh MS, Kumar MS, Kemparaju K, Girish KS. Inhibition of hemorrhagic activity of viper venoms by N-acetyl cysteine: involvement of N-acetyl and thiol groups. Curr Top Med Chem. 2011;11(20):2589-2600. doi:10.2174/156802611797633401
  • 85. Pithayanukul P, Leanpolchareanchai J, Saparpakorn P. Molecular docking studies and anti-snake venom metalloproteinase activity of Thai mango seed kernel extract. Molecules. 2009;14(9):3198-3213. doi:10.3390/molecules14093198
  • 86. Santhosh MS, Hemshekhar M, Sunitha K, et al. Snake venom induced local toxicities: plant secondary metabolites as an auxiliary therapy. Mini Rev Med Chem. 2013;13(1):106-123. https://pubmed.ncbi.nlm.nih.gov/22876950/
  • 87. van Acker SA, van den Berg DJ, Tromp MN, et al. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med. 1996;20(3):331-342. doi:10.1016/0891-5849(95)02047-0
  • 88. Khokhar S, Owusu-Apenten R. Iron binding characteristics of phenolic compounds: some tentative structure-activity relations. Food Chem. 2003;81(1):133-140. doi:10.1016/S0308-8146(02)00394-1
  • 89. Karamać M. Fe(II), Cu(II) and Zn(II) chelating activity of buckwheat and buckwheat groats tannin fractions. Polish J Food Nutr Sci. 2007;57(4):357-362. https://www.researchgate.net/publication/237063180_FeII_CuII_and_ZnII_chelating_activity_of_buckwheat_and_buckwheat_groats_tannin_fractions/citation/download
  • 90. Alam MN, Chowdhury MI, Kamal M, et al. Radioactivity in sediments of the Karnaphuli river estuary and the Bay of Bengal. Health Phys. 1997;73(2):385-387. doi:10.1097/00004032-199708000-00013
  • 91. Fruton JS. Edwin J. Cohn and the development of protein chemistry. With a detailed account of his work on the fractionation of blood during and after World War II. J Hist Med Allied Sci. 2004;59(2):309-311. doi:10.1093/jhmas/59.2.309
  • 92. Matejtschuk P, Dash CH, Gascoigne EW. Production of human albumin solution: a continually developing colloid. Br J Anaesth. 2000;85(6):887-895. doi:10.1093/bja/85.6.887
  • 93. Brodniewicz-Proba T. Human plasma fractionation and the impact of new technologies on the use and quality of plasma-derived products. Blood Rev. 1991;5(4):245-257. doi:10.1016/0268-960x(91)90016-6
  • 94. Koh DC, Armugam A, Jeyaseelan K. Snake venom components and their applications in biomedicine. Cell Mol Life Sci. 2006;63(24):3030-3041. doi:10.1007/s00018-006-6315-0
  • 95. Fatima L, Fatah C. Pathophysiological and Pharmacological Effects of Snake Venom Components: Molecular Targets. J Clin Toxicol. 2014;4(2): 1000190. doi:10.4172/2161-0495.190